![Kathryn M. McNeil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathryn M. McNeil
Plus aucun poste en cours
Profil
Kathryn M.
McNeil worked as Head-Investor & Media Relations at Chelsea Therapeutics International Ltd. from 2009 to 2012.
She was also VP-Investor Relations & Public Relations at Novelos Therapeutics, Inc. from 2013 to 2014, and VP-Investor Relations & Corporate Communications at Cellectar Biosciences, Inc. from 2013 to 2015.
In 2017, she worked as Head-Communication & Investor Relations at Invitae Corp.
Ms. McNeil obtained an undergraduate degree from Wesleyan University.
Anciens postes connus de Kathryn M. McNeil
| Sociétés | Poste | Fin |
|---|---|---|
| INVITAE CORPORATION | Public Communications Contact | 01/04/2018 |
| CELLECTAR BIOSCIENCES, INC. | Investor Relations Contact | 28/07/2015 |
Novelos Therapeutics, Inc.
 Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Investor Relations Contact | 12/02/2014 |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Investor Relations Contact | - |
Formation de Kathryn M. McNeil
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases | Health Technology |
Invitae Corp.
 Invitae Corp. Medical/Nursing ServicesHealth Services Provides genetic testing services for patients | Health Services |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
